Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07483320 · ClinicalTrials.gov registry record · NA
Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy
A NA study, sponsored by Spaulding Rehabilitation Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07483320 is a NA study that has not yet begun recruiting, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 100 participants.
The verdict
NCT07483320, a NA study, has not yet begun recruiting, sponsored by Spaulding Rehabilitation Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Midportion Achilles tendinopathy is a common cause of pain and functional limitation in both athletes and the general population. Progressive tendon loading programs are considered first-line treatment but do not lead to satisfactory outcomes in all patients. Extracorporeal shockwave therapy (ESWT) and platelet-rich plasma (PRP) injections are commonly used interventions for refractory symptoms, yet evidence supporting their combined use is limited particularly in treating Achilles tendon disorders. This randomized controlled trial will evaluate the effectiveness of a standardized exercise program alone or in combination with PRP injection, ESWT, or both therapies in active adults with midportion Achilles tendinopathy. Participants will be randomized to one of four treatment groups and followed for six months. The primary outcome will assess changes in Achilles tendon symptoms and function using the Victorian Institute of Sport Assessment-Achilles (VISA-A) score. Secondary outcomes will include patient-reported outcomes, physical function testing, ultrasound tendon structure measures, and gait biomechanics.
Interventions
- DEVICE Platelet Rich Plasma
- DEVICE Extracorporeal Shockwave Therapy
- DEVICE Sham PRP
- DEVICE Sham ESWT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07483320
The ClinicalTrials.gov registry entry for NCT07483320 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Platelet Rich Plasma is the first listed.
NCT07483320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07483320 about?
NCT07483320 is a clinical study titled "Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy". Midportion Achilles tendinopathy is a common cause of pain and functional limitation in both athletes and the general population. Progressive tendon loading programs are considered first-line treatment but do not lead to satisfactory outcomes in all patients. Extracorporeal shockwave therapy (ESWT) ...
What is the current status of trial NCT07483320?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-06-01. Estimated completion is 2028-05-30.
What interventions are being tested in trial NCT07483320?
The interventions under investigation include: Platelet Rich Plasma (DEVICE), Extracorporeal Shockwave Therapy (DEVICE), Sham PRP (DEVICE), Sham ESWT (DEVICE).
Who is sponsoring clinical trial NCT07483320?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.